Profile of liver cholestatic biomarkers following prolonged ketamine administration in patients with COVID-19
To investigate the possible influence of prolonged ketamine (K) or esketamine (ESK) infusion on the profile of liver cholestatic biomarkers in patients with COVID-19 infection.
Saved in:
Main Authors: | Julie, Henrie, Ludovic, Gerard, Caroline Declerfayt, Declerfayt |
---|---|
Format: | Book |
Language: | English |
Published: |
Springer
2023
|
Subjects: | |
Online Access: | https://link.springer.com/article/10.1186/s12871-023-02006-2 https://dlib.phenikaa-uni.edu.vn/handle/PNK/7097 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Liver Glycogen as a Sensitive Indicator of Food Limitation in Delta Smelt
by: Dhayalan, Tena S., et al.
Published: (2023) -
Cerebrospinal Fluid Profile of Lipid Mediators in Alzheimer’s Disease
by: Khanh V. Do, et al.
Published: (2022) -
Dammarane triterpenes and phytosterols from Dysoxylum tpongense Pierre and their anti-inflammatory activity against liver X receptors and NF-κB activation
by: Ngoc Khanh Pham, et al.
Published: (2021) -
Diagnosis and Management of Posterior Cortical Atrophy
by: Keir X. X. Yong, Yong, et al.
Published: (2023) -
The cytokine adsorber Cytosorb® does not reduce ammonia concentrations in critically ill patients with liver failure
by: Uwe, Liebchen, et al.
Published: (2023)